2025 Earnings Presentations Avient Q2 2025 Earnings - August 1, 2025 Avient Q1 2025 Earnings - May 6, 2025 

2025 Earnings Presentations Avient Q2 2025 Earnings - August 1, 2025 Avient Q1 2025 Earnings - May 6, 2025 

2025 Earnings Presentations Avient Q2 2025 Earnings - August 1, 2025 Avient Q1 2025 Earnings - May 6, 2025 

Bob Patterson Chairman, President, and CEO February 2, 2022 SAFETY & HEALTH POLICY Avient Corporation believes that safety and health are the highest corporate priority. As a member of the American Chemistry Council, we have adopted Responsible Care® Guiding Principles and the Process Safety Management Practices to continuously guide our efforts to improve safety performance. Our practices reinforce these imperatives, and our commitment to excellence in safety and health is absolute.

CESA™ Block Additives Antiblocking PRODUCT SELECTION GUIDE Unmodified film and sheet can adhere, causing problems of separation. CESA™ Block additives modify the surface characteristics and improve the coefficient of the friction of the sheet or film, preventing self-adhesion.

Bob Patterson Chairman, President, and CEO August 1, 2020 SAFETY & HEALTH POLICY Avient Corporation believes safety and health are the highest corporate priority. As a member of the American Chemistry Council, we have adopted Responsible Care® Guiding Principles and the Process Safety Management Practices to guide our efforts in continuous improvement in safety performance. Our commitment to excellence in safety and health is absolute.

& Canada EMEA Asia Latin America 64% 36% Specialty Engineered Materials Color Additives and Inks 41% 36% 18% 5% 7% 7% 23% 19% 9% 16% 10% 5% 4% Defense Healthcare Packaging Consumer Building & Construction Industrial Transportation Energy Telecom Geography Segment Industry 2024 Financial Guidance $525 to $530 million Adjusted EBITDA $2.63 to $2.67 Adjusted EPS 4 Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile Avient CDP Score: A- SUSTAINABILITY PERFORMANCE AND RECOGNITION O CTO BE R 3 1 , 2024 W EB CAS T P RE SE N TATI O N 6 Q3 2024 HIGHLIGHTS • 8.5% organic sales growth driven by broad-based growth across all regions and most end markets in both CAI and SEM segments • Growth stemmed from gaining share, winning new product specifications and restocking in certain end markets • Both segments expanded YoY EBITDA margins by 40 bps each • Adjusted EPS of $0.65, an increase of 14% vs the prior year • Successfully refinanced $650M outstanding senior notes due 2025; extending maturity to 2031 • Increased dividend 5% to $1.08 on an annualized basis; 14th consecutive increase Adj. FX +8.5% FX -0.4% Total Avient +8.1% Note: Regional Sales Percentages exclude impact of foreign exchange COLOR, ADDITIVES & INKS SEGMENT (Q3 2024 PERFORMANCE VS Q3 2023) $487 $522 Q3 23 Q3 24 $89 $97 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 10 + 7% (+8% excluding FX) + 9% (+11% excluding FX) 18.3% +40 bps *18.7% * * Adjusted EBITDA Margin % • Sales growth driven by winning new product specifications in consumer & packaging, strong underlying demand in healthcare and improving demand in building & construction • Favorable mix and raw material deflation contributed to EBITDA margin expansion SPECIALTY ENGINEERED MATERIALS SEGMENT (Q3 2024 PERFORMANCE VS Q3 2023) $268 $295 Q3 23 Q3 24 $51 $57 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 11 • Sales growth driven by restocking in healthcare & consumer end markets and strong underlying demand for composite applications used in building & construction, energy and defense end markets • Favorable mix contributed to EBITDA margin expansion + 10% (+10% excluding FX) + 12% (+13% excluding FX) 19.0% +40 bps *19.4% * * Adjusted EBITDA Margin % 2024 G U IDA N CE FY 2024 GUIDANCE Previous (Aug 6) Current Adjusted EPS $2.55 to $2.70 $2.63 to $2.67 Adjusted EBITDA $515 to $540 million $525 to $530 million Interest Expense $105 million $104 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures & Investment in S/4 Hana ~$140 million ~$140 million 13 14 • Investor Day to be held December 4, 2024 at the NYSE, beginning at 10AM • The focus will be to do a deep dive on the Company’s strategy • Registration available at www.avient.com/investors 2024 AVIENT INVESTOR DAY AP P EN D IX 17 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 19 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 20 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION US & Canada 52% EMEA 35% Asia 13% 21 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2023 AVIENT REGIONAL SALES Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 22 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Despite using an acrylic sheet with built-in light diffusion technology, the light source was plagued by visual “hot spots.” Also, the acrylic sheets required an additional process to cut them to size before thermoforming, which led to excessive waste and disposal costs. Instead of purchasing pre-fabricated acrylic sheet that contained a costly diffusion additive, the Smartbatch solution enabled the customer to reduce its material costs by 50%.

Microsoft Word - EHS Committee Charter (Amended July 2022).doc AVIENT CORPORATION ENVIRONMENTAL, HEALTH AND SAFETY COMMITTEE CHARTER Membership • Members of the Environmental, Health and Safety Committee (the “Committee”) of the Board of Directors (the “Board”) of Avient Corporation (the “Company”) will be appointed by the Board each year. • Each Committee member will serve at the pleasure of the Board for such term as the Board may decide. Duties and Responsibilities The Committee will: Assessment Process • Periodically review the results of formal assessments by management of the environmental liabilities for which the Company has known or probable environmental exposure and the adequacy of the Company’s financial reserves for environmental liabilities; • Semi-annually review the status of health and safety performance of the Company; • Semi-annually review the status of the Company’s product stewardship programs and performance; • Periodically review the Company’s staffing for its environmental, health and safety assessments and compliance; and 2 • Periodically review new environmental, physical security, health and safety laws and regulations applicable to the Company’s operations and issues or significant developments arising from pending regulatory and citizen group activities. Compliance Programs • At least annually review the programs and procedures established by the Company that monitor compliance with the Company’s policies, standards and practices, and laws and regulations with respect to safety, health, environmental, physical security and product stewardship, including providing oversight of the systems that are in place to monitor and mitigate the Company’s carbon footprint and physical risks associated with climate change; • Periodically review with management the significant safety, health, environmental, physical security, and product stewardship risks or exposures faced by the Company, if any, and steps taken by management to minimize such risks and exposures to the Company and its constituencies; • At least annually review the status of the Company’s environmental and safety audit process, assessing compliance with Company policies, standards, practices, laws and regulations; and • Periodically review claims, demands, administrative orders and legal proceedings against the Company regarding safety, health, environmental, physical security and product stewardship matters.

Jan 29, 2025 Based on PCR spectral data, the tool delivers the calculated spectra, a final color visualization and offers three-dimensional color space simulations, that covers the workable color space.